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Abstract
Although the advanced stages of neoplasms have a risk of superior mesenteric venous thrombosis (MVT), an initial
clinical diagnosis of MVT is sometimes difficult and it can be treated as a cancer-related pain using NSAIDs and/or
opioids.
We herein present a case of palliative stage of cancer with acute MVT, which was successfully treated with
immediate anticoagulant therapy. We believe this case provides an important clinical lesson, which is that we
should remember that MVT is one of the potential causes of abdominal pain with cancer patients and the throm-
bosis can be easily identified by US and CT.
Introduction
Although the advanced stage of the neoplasm has a risk
of superior mesenteric venous thrombosis (MVT) [1],
an initial clinical diagnosis of MVT is sometimes diffi-
cult and it can be treated as a cancer-related pain. We
herein present a case of palliative stage of cancer with
acute MVT, which was successfully treated with
immediate anticoagulant therapy. His clinical course
suggests we should remember that MVT is one of the
potential causes of abdominal pain with cancer patients
and the thrombosis can be easily identified by US
and CT.
Case presentation
A 69-year-old male was admitted because of a continu-
ally worsening abdominal cramping pain, which had
started two days before his admission. The pain was
radiating to his back and it was associated with nausea
and appetite loss. The patient had previously undergone
a total gastrectomy for advanced gastric cancer two
years earlier.
Thereafter, peritoneal relapse occurred and chemother-
apy with paclitaxel and S-1 was administered by the out-
patient department for six months with uneventfully. At
admission, he was fully alert and his vital signs were
normal, although he had mild grade fever (37.5°C). On
examination, his abdomen was soft and flat with abdom-
inal tenderness at the epigastrium, with diminished bowel
sounds. Biochemical results and coagulation studies were
within the normal limits. However, his symptoms were
getting worse and opioid titillation was thus initiated. He
underwent abdominal ultrasonography (US), which
showed evidence of thrombosis or tumor thrombosis in
the portal vein. A contrast-enhanced CT scan showed
evidence of superior mesenteric venous thrombosis asso-
ciated with thrombosis of the portal vein without caver-
nous formation(Figure 1). There was no thrombosis in
the splenic vein (Figure 2). The dehydration was cor-
rected by the fluid therapy. Anticoagulant therapy was
started, because the thrombosis had formed recently and
the risk of bleeding was low. The patient was given low-
molecular-weight heparin (Dalteparin sodium, Fragmin)
at a dosage of 10,000 U per day. Three days after the
administration of heparin, he had a complete recovery
from abdominal pain without opioid use and was thus
able to start eating. He was discharged after 14 days of
admission with a shift of the anticoagulant therapy to
warfarin with a targeted international normalized ratio
(PT-INR) of 1.5-2.0. Three months later, he was doing
well and the thrombosis of the superior mesenteric vein
and portal vein had completely disappeared on a follow-
up CT. Six months later, he died from gastric cancer and
the autopsy showed no thrombosis in the superior
mesenteric vein and portal vein.
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MVT has been assumed to be a very rare disease. The
incidence of MVT was estimated at 1.8-2·7 per 100 000
person-years[2,3]. This accounts for 1.5-6.2% of patients
of acute mesenteric ischemia in various studies[4]. The
neoplasm is among the more common causes of mesen-
teric venous thrombosis. As illustrated in Table 1, 83
(21%) of 395 cases of MVT associated with neoplasm
[2-7]. The advanced stage of the neoplasm has a risk of
developing MVT such as, hyper-coagulability, a low flow
state in the superior mesenteric vein as a result of dehy-
dration and chemotherapy [5,8,9].
The clinical diagnosis of MVT associated with a neo-
plasm is sometimes difficult. The symptoms and signs
of MVT are non-specific, such as abdominal pain with
nausea, vomiting, diarrhea/constipation and fever [4],
and the initial physical findings may often appear to be
entirely normal. These conditions are often assumed to
be cancer related symptoms, which can be treated with
NSAIDs and/or opioids. In the present case, the initial
diagnosis was cancer-related pain during chemotherapy
for gastric cancer with peritonitis carcinomatosa.
The use of advanced imaging techniques provided
useful and helpful information. US is a powerful modal-
ity for the screening of a suspected thrombosis. Con-
trast-enhanced CT, which facilitates the early and
accurate detection of thrombosis, including fresh throm-
bosis with a high sensitivity [4], therefore indicated the
precise location of the thrombosis and the duration of
the thrombosis in this case.
The best strategy for MVT is its early diagnosis and
immediate treatment [1]. Anticoagulant therapy, which
generally allows for the re-canalization of the throm-
bosed vein in recently formed thromboses, is recom-
mended in patients with acute MVT to improve the
survival without increasing the risk of bleeding [4,10],
however, reliable data for the palliative stage of cancer
patients with MVT is still scarce.
Conclusion
The palliative stage of a cancer patient with MVT was
successfully treated. It is important to remember that
MVT is one of the causes of abdominal pain in cancer
patients and such thrombosis can be easily identified by
both US and CT. Even in palliative stage cancer patients,
the immediate use of anticoagulants can improve both
the QOL and the prognosis of the patients.
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Figure 1 Contrast-enhanced abdominal CT.T h et h r o m b o s i s
located in the superior mesenteric vein with portal vein (arrow)
without cavernous formation.
Figure 2 Contrast-enhanced abdominal CT.N ot h r o m b o s i sw a s
observed in the splenic vein (arrow).
Table 1 Incidence of Cancer relative MVT
Authors term cases cancer related cases
Acosta, S(2005) [2] 1970-1982 23 8 (35%)
Acosta, S(2008) [3] 2000-2006 51 12 (24%)
Kumar, S(2003) [4] 1979-1998 69 9 (13%)
Janssen, HL(2001)[5] 1984-1997 172 41(24%)
Sogaard K(2001)[6] 1992-2005 67 9 (13%)
Morasch, MD(2001)[7] 1985-1999 13 4 (31%)
total 395 83 (21%)
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